BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., Aug. 27 /PRNewswire-FirstCall/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX), a global medical technology company,
announced today that it would present at the following investor healthcare
conferences:
Thomas Weisel Healthcare Conference 2008
September 4, 2008
1:30 p.m. EDT

Morgan Stanley Global Healthcare Unplugged Conference
September 9, 2008
8:00 a.m. EDT

A live webcast of BD's presentations can be accessed from the BD corporate
website at www.bd.com/investors. They will be available for replay for a
period of seven days.
BD is a leading global medical technology company that develops,
manufactures and sells medical devices, instrument systems and reagents. The
Company is dedicated to improving people's health throughout the world. BD is
focused on improving drug delivery, enhancing the quality and speed of
diagnosing infectious diseases and cancers, and advancing research, discovery
and production of new drugs and vaccines. BD's capabilities are instrumental
in combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000
people in approximately 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public.
For more information, please visit www.bd.com.
SOURCE BD (Becton, Dickinson and Company)

Patricia A. Spinella, Investor Relations, +1-201-847-5453, or Colleen T.
White, Corporate Communications, +1-201-847-5369, both of BD